Description
Comprehensive clinical analysis of alopecia: Pathophysiology, diagnostic frameworks, and integrative therapeutic strategies
The medical world often views hair as a purely aesthetic appendage, but for us, followers of the healing art, it is a barometer of internal health and a mirror of physiological balance. Alopecia, in its various forms, is not simply a loss of strands, but a complex disruption of the body’s biological rhythms, influenced by genetics, the immune system and the environment. As ” Asclepius” , I invite you to immerse yourself in this knowledge with a reverence for science and empathy for the suffering person, guided by the principle of Primum non nocere . This report is intended for physicians and medical students, aiming to provide the deepest possible understanding of this pathology by synthesizing the classical analytical approach of French’s Index and the pathophysiological depth of Harrison’s Principles of Internal Medicine.
Definition and biological context of pathology
Alopecia is defined as pathological hair loss, which may be scarring or non-scarring, localized or diffuse, reversible or permanent. To understand alopecia, we must first understand the cyclical nature of the hair follicle, one of the most metabolically active organs in the human body. Each follicle goes through three main phases, which Harrison’s Principles define as fundamental to scalp homeostasis:
- Anagen: A phase of active growth lasting from 2 to 7 years. In a healthy adult, about 86% of hair is in this phase.
- Catagen: A short transitional phase of involution (about 2-3 weeks) in which the follicle shrinks.
- Telogen: Resting phase (about 3 months), ending with hair loss (exogenous).
Alopecia occurs when these phases are shortened or interrupted by external or internal aggressors. For example, in androgenetic alopecia, the anagen phase is progressively shortened, leading to follicle miniaturization – a process in which terminal (long and pigmented) hairs are replaced by vellus (fine and colorless) hairs.
Epidemiology: Global scale of follicular health
The epidemiological profile of alopecia shows significant variations depending on gender, age and ethnicity. Androgenetic alopecia (AGA) remains the most common form of hair loss worldwide.
Table 1: Epidemiological data by types of alopecia
| Pathology | Prevalence / Frequency | Demographic characteristics |
| Androgenic alopecia (Men) | 25% at 25; 42% total; up to 80% at 70. | Highest in Caucasians; lower in Asians and Africans. |
| Androgenic alopecia (Women) | 40-50% of women by age 70 | It often accelerates during menopause. |
| Alopecia areata (AA) | Lifetime prevalence around 2% | It affects all ages, often starting in childhood. |
| Telogen effluvium (TE) | The exact prevalence is difficult to determine due to the transient nature | Very common after childbirth, severe infections or stress. |
| Trichotillomania | Female:male ratio is 2.5:1 | More common in children and adolescents. |
These data highlight the importance of genetic predisposition. In AGA, inheritance is polygenic, involving genes regulating androgen receptors and the enzyme 5-alpha reductase. Alopecia areata is often associated with other autoimmune conditions such as vitiligo, type 1 diabetes, and Hashimoto’s thyroiditis.
Classification of alopecia
In medical practice, classification is crucial for prognosis. The main division is made based on the presence or absence of cicatrization (scarring).
- Non-scarring alopecia
In these conditions, the follicular openings are preserved and there is a potential for complete hair restoration.
- Androgenic alopecia (AGA): Genetically caused miniaturization.
- Alopecia areata (AA): An autoimmune attack against the follicle.
- Telogen effluvium: Diffuse shedding due to stressful transition of hairs into telogen.
- Anagen effluvium: Rapid loss due to toxic damage to dividing cells (e.g. chemotherapy).
- Traction alopecia: Mechanical damage due to tension.
- Scarring/Cicatricial alopecia
Here, irreversible destruction of the hair follicle occurs and its replacement with fibrous tissue.
- Lichen planopilaris (LPP): Lymphocytic inflammation.
- Discoid lupus erythematosus (DLE): Characterized by follicular blockage and atrophy.
- Folliculitis decalvans: Neutrophilic inflammation leading to the appearance of ” bundles” of hair .
Pathophysiology according to Harrison’s Principles
The pathophysiological mechanism varies dramatically between different forms of alopecia, each reflecting a specific disruption in cell signaling.
Molecular basis of androgenetic alopecia
The central role here is played by dihydrotestosterone (DHT). Testosterone is converted to DHT by the enzyme 5-alpha reductase (type 2). DHT binds to androgen receptors in the dermal papilla, which triggers a series of events:
- Shortening of the anagen phase.
- Prolongation of the telogen phase (the period between hair loss and new hair growth becomes longer).
- Follicular miniaturization: follicles become shallower and smaller, producing increasingly finer strands. In women, the role of androgens is more complex; aromatase is often involved, which converts androgens to estrogens, which may explain why women rarely achieve complete baldness.
Immune collapse in alopecia areata
Under healthy conditions, the hair follicle enjoys “immune privilege” – it is protected from recognition by the immune system. In alopecia areata, this privilege collapses. Cytotoxic CD8+ NKG2D+ T cells attack the follicular bulb. This process is mediated by the JAK-STAT signaling pathway, which involves interferon-gamma (IFN-$\gamma$) and interleukin-15 (IL-15). This leads to a sudden cessation of growth and entry into telogen.
Iron deficiency and telogen effluvium
Iron is a critical cofactor for ribonucleotide reductase, an enzyme required for DNA synthesis in rapidly dividing cells of the hair matrix. When ferritin (storage iron) levels fall below a critical threshold (often below 30-70 ng/mL), the body prioritizes iron for hemoglobin over hair, leading to diffuse hair loss.
Clinical manifestation
The clinical picture is our main guide in differential diagnosis.
AGA fall patterns
- Male type: Begins with bilateral recession of the forehead line (bitemporal recession), followed by thinning of the vertex. It is assessed using the Hamilton-Norwood scale.
- Female type: Diffuse thinning on the top of the head with preservation of the frontal hairline (Ludwig scale). May also manifest as a “Christmas tree” pattern – widening of the central pathway.
Characteristics of alopecia areata
The typical finding is the sudden appearance of round or oval smooth patches without hair. At the edges of active foci, “exclamation mark hairs ” are often seen – short hairs that are thinner at the base. In severe cases , Alopecia Totalis (loss of the entire scalp) or Alopecia Universalis (loss of hair on the entire body) develops .
Signs of cicatricial alopecia
Physical examination often reveals erythema, perifollicular scaling, pustules, or skin atrophy. The absence of visible follicular openings is a sure sign of scarring. Patients often report itching, soreness, or burning.
Diagnostics and research
The diagnostic process must be precise and empathetic, aiming not only to name the disease, but also to discover systemic causes.
Laboratory tests
Not every alopecia requires a full panel, but in diffuse hair loss the following tests are necessary:
- Serum ferritin: The most sensitive marker of iron deficiency. Levels below 30-70 $\mu g/L$ are often associated with hair loss.
- TSH: To rule out hypo- or hyperthyroidism.
- Complete blood count (CBC): To evaluate for anemia or systemic inflammation.
- VDRL/RPR: In case of suspected syphilis (” moth-bitten” appearance of the hair).
- Hormonal panel (in women): Free and total testosterone, DHEA-S, and prolactin if signs of hyperandrogenism such as hirsutism or acne are present.
Trichoscopy (Scalp Dermatoscopy)
This is the “gold standard” for non-invasive diagnostics.
- In AGA: Variability in hair diameter >20% (the most important criterion), perifollicular hyperpigmentation (halos).
- In AA: Yellow dots (keratin plugs), black dots (cadaveric hairs), ingrown hairs.
- In Tinea Capitis: Comma-shaped or corkscrew-shaped hair strands.
Severity assessment: SALT Score
The Severity of Alopecia Tool (SALT) is used to quantify the loss in alopecia areata. The scalp is divided into four zones:
- Vertex: 40% of the area.
- Right profile: 18%.
- Left profile: 18%.
- Occiput: 24%. The percentage loss in each area is multiplied by its severity and summed for a final score from 0 to 100.
Differential diagnosis according to French’s Index
The French’s Index methodology requires us to analyze the symptom ” hair loss” through the prism of probability and severity.
Table 2: Differential diagnostic analysis
| Symptom / Finding | Most likely diagnosis (Probability) | Very serious diagnosis (Severity) | Differentiating features |
| Round foci without hair | Alopecia areata | Alopecia neoplastica (metastases) | In AA, the skin is smooth; in neoplasia, it is often dense/nodular. |
| Diffuse thinning | Telogen effluvium | Systemic Lupus (SLE) or Syphilis | In effluvium, there is a trigger (stress); in SLE, there are systemic symptoms. |
| Thinning with peeling | Seborrheic dermatitis | Tinea Capitis (fungus) | Tinea causes hair breakage; dermatitis does not. |
| Scarring loss | Lichen planopilaris | Discoid Lupus (DLE) | DLE has marked follicular obstruction; LPP has perifollicular erythema. |
The doctor should always look for the “wonder hairs” for AA and perform a “pull test.” A positive test (>6 hairs pulled) indicates an active process.
Alopecia therapy
Treatment requires a holistic approach, combining the power of modern pharmacology with the beneficial effects of nature.
Pharmacotherapeutic targets
- Stopping hair loss: Stabilizing follicles.
- Growth stimulation: Anagen elongation.
- Immunomodulation: In autoimmune forms.
Classical pharmacotherapy
- Finasteride: Oral 5-alpha reductase type 2 inhibitor. Dose: $1~mg/day$ for men. Results after 3-6 months. Potential side effects: decreased libido, erectile dysfunction (~2%).
- Minoxidil: Topical vasodilator. Dose: 5% solution or foam twice daily. Increases blood supply to the follicle. May cause local irritation.
- Corticosteroids: Intralesional injection (e.g., triamcinolone acetonide $5~mg/mL$) is the first-line treatment for alopecia areata. Repeat every 4-6 weeks.
- JAK inhibitors (New Era): Baricitinib and Ritlecitinib are FDA-approved for severe alopecia areata. They block the immune system signals that attack hair.
Holistic and integrative approaches
- Saw Palmetto (Serenoa repens): Natural 5-alpha reductase inhibitor. Used for AGA. Dosage: Standardized extract of 320 mg/day.
- Pumpkin seed oil: Has shown benefits in men with AGA, possibly through an antiandrogenic effect.
- Essential oils: Scalp massage with a blend of rosemary, thyme, lavender, and cedarwood has been shown to be effective for alopecia areata in controlled studies.
- Nutritional support: Biotin (5 mg/day), zinc and iron if deficiency is identified.
Potential interactions and warnings
As your advisor, I am obliged to warn about the possible risks of combining therapies:
- Finasteride and St. John’s wort: St. John’s wort can induce liver enzymes that reduce blood levels of finasteride, making it less effective.
- Minoxidil and Alcohol: Alcohol can enhance the vasodilating effect of minoxidil, which may lead to dizziness or low blood pressure.
- Saw Palmetto and Anticoagulants: There is a theoretical risk of increased bleeding if taken with aspirin or warfarin.
- Griseofulvin (for fungus) and Oral contraceptives: Reduces the effect of contraceptives; additional protection is necessary.
Conclusion and ethical guidelines
The journey to hair restoration is a marathon, not a sprint. It requires patience, scientific precision, and attention to the patient’s soul. Hair is a symbol of our vitality, and losing it can cause severe psychological wounds. Always remember that the body seeks balance (homeostasis) and our role is to help it find it again.
Important reminder: This analysis is advisory and is intended to expand your medical understanding. For any serious condition, a physical examination by a specialist doctor (dermatologist) is imperative to confirm the diagnosis and prescribe personalized treatment.
